Beauvericin

CAS No. 26048-05-5

Beauvericin( Beauvericin )

Catalog No. M13791 CAS No. 26048-05-5

Beauvericin is a cyclic hexadepsipeptide with antibiotic and insecticidal effects, shows activity against Gram-positive bacteria and mycobacteria.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Beauvericin
  • Note
    Research use only, not for human use.
  • Brief Description
    Beauvericin is a cyclic hexadepsipeptide with antibiotic and insecticidal effects, shows activity against Gram-positive bacteria and mycobacteria.
  • Description
    Beauvericin is a cyclic hexadepsipeptide with antibiotic and insecticidal effects, shows activity against Gram-positive bacteria and mycobacteria, and is also capable of inducing programmed cell death in mammals.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Beauvericin
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    26048-05-5
  • Formula Weight
    784
  • Molecular Formula
    C45H57N3O9
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (127.56 mM)
  • SMILES
    O=C([C@H](CC1=CC=CC=C1)N(C)C([C@@H](C(C)C)OC([C@H](CC2=CC=CC=C2)N(C)C([C@@H](C(C)C)OC([C@H](CC3=CC=CC=C3)N4C)=O)=O)=O)=O)O[C@H](C(C)C)C4=O
  • Chemical Name
    cyclo[(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-phenylalanyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-phenylalanyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-phenylalanyl]

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Logrieco A, et al. Appl Environ Microbiol. 1998 Aug;64(8):3084-8. 2. Tonshin AA, et al. Toxicology. 2010 Sep 30;276(1):49-57.
molnova catalog
related products
  • Finafloxacin

    Finafloxacin is a fluoroquinolone antibiotic that demonstrates superior activity to ciprofloxacin under acidic conditions (pH5.8, A. baumannii isolates MIC=0.03-0.12ug/mL).

  • PGLa

    PGLa is a cationic antimicrobial peptide (AMP) originally isolated from frog. It has been shown to have antibacterial,antifungal,and antiviral,activities.

  • JSF-4088

    JSF-4088 (JSF4088) is a novel antitubercular agent with potent in vitro antitubercular potency (MIC=19 nM).